A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes

Clinica Chimica Acta

Volumn 376, Issue 1-2, 2007, Pages 168-173

  Cameron, Scott J ^a   Sokoll, Lori J ^a   Laterza, Omar F ^a   Shah, Sanket ^b   Green, Gary B ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Department of Emergency Medicine ^*  (United States)

Author keywords

Acute coronary syndromes; Biomarkers; CK MB; hs CRP; Myoglobin; NT proBNP; Risk stratification; Troponin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; MYOGLOBIN; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; EMERGENCY WARD; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POPULATION; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATINE KINASE, MITOCHONDRIAL FORM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TROPONIN T;

ANGINA;

EID: 33845329895     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.08.019     Document Type: Article

References (33)

1. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
3. Sobel B.E., Roberts R., and Larson K.B. Estimation of infarct size from serum MB creatine phosphokinase activity: applications and limitations. Am J Cardiol 37 (1976) 474-485
4. Wu A.H., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., and Valdes Jr. R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 45 (1999) 1104-1121
5. Chrysohoou C., Pitsavos C., Panagiotakos D.B., Kokkinos P.F., Stefanadis C., and Toutouzas P. The association between physical activity and the development of acute coronary syndromes in treated and untreated hypertensive subjects. J Clin Hypertens (Greenwich) 5 (2003) 115-120
6. Collinson P.O., Premachandram S., and Hashemi K. Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department. BMJ 320 (2000) 1702-1705
7. Ritter D., Lee P.A., Taylor J.F., et al. Troponin I in patients without chest pain. Clin Chem 50 (2004) 112-119
8. Cohn P.F., Fox K.M., and Daly C. Silent myocardial ischemia. Circulation 108 (2003) 1263-1277
9. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in myocardial infarction. J Am Coll Cardiol 31 (1998) 1460-1465
10. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
11. Green G.B., Li D.J., Bessman E.S., Cox J.L., Kelen G.D., and Chan D.W. The prognostic significance of troponin I and troponin T. Acad Emerg Med 5 (1998) 758-767
12. Groenning B.A., Nilsson J.C., Sondergaard L., et al. Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 143 (2002) 923-929
13. Goetze J.P., Christoffersen C., Perko M., et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 17 (2003) 1105-1107
14. Campbell D.J., Munir V., Hennessy O.F., and Dent A.W. Plasma amino-terminal pro-brain natriuretic peptide levels in subjects presenting to the Emergency Department with suspected acute coronary syndrome: possible role in selecting patients for follow up?. Intern Med J 31 (2001) 211-219
15. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
16. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106 (2002) 2913-2918
17. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
18. Laterza O.F., Cameron S.J., Chappell D., Sokoll L.J., and Green G.B. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta 348 (2004) 163-169
19. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., and Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90 (1994) 583-612
20. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
21. Green G.B., Skarbek-Borowski G.W., Chan D.W., and Kelen G.D. Myoglobin for early risk stratification of emergency department patients with possible myocardial ischemia. Acad Emerg Med 7 (2000) 625-636
22. Leoncini M., Maioli M., Bellandi F., et al. Therapeutic strategies, immediate and mid-term outcomes in non-ST-segment elevation acute coronary syndromes with respect to age: a single-center registry of 488 consecutive patients. Clin Cardiol 27 (2004) 475-479
23. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
24. Arakawa N., Nakamura M., Aoki H., and Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27 (1996) 1656-1661
25. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
26. Hamm C.W., Heeschen C., Goldmann B., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 340 (1999) 1623-1629
27. Yan A.T., Yan R.T., Tan M., et al. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients. Eur Heart J 25 (2004) 2006-2012
28. Mair J., Wagner I., Jakob G., et al. Different time courses of cardiac contractile proteins after acute myocardial infarction. Clin Chim Acta 231 (1994) 47-60
29. de Lemos J.A., Morrow D.A., Gibson C.M., et al. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol 40 (2002) 238-244
30. Nomoto K., Oguchi S., Watanabe I., Kushiro T., and Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 42 (2003) 201-206
31. Jialal I., and Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol 116 (2001) S108-S115 [Suppl]
32. Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 105 (2002) 2019-2023
33. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397